Minor components of pomace olive oil enhance VLDL-receptor expression in macrophages when treated with postprandial triglyceride-rich lipoproteins

  1. R. Cabello-Moruno 1
  2. L. Sinausia 1
  3. E. Montero 2
  4. K.M. Botham 3
  5. M. Avella 3
  6. J.S. Perona 4
  1. 1 Universidad Pablo de Olavide, Seville, Spain
  2. 2 General Hospital. HHUU Virgen del Rocío, Seville, Spain
  3. 3 The Royal Veterinary College, London, United Kingdom
  4. 4 Universidad Pablo de Olavide, Seville
Mostrar afiliaciones +
Revista:
Grasas y aceites

ISSN: 0017-3495,  1988-4214

Año de publicación: 2015

Volumen: 66

Número: 4

Tipo: Artículo

DOI: 10.3989/GYA.0109151 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Grasas y aceites

Resumen

El aceite de orujo de oliva (AOO) es rico en componentes menores que pueden modular la composición de lipoproteínas ricas en triglicéridos postprandiales (TRL) y su captación por macrófagos. El objetivo del presente estudio fue investigar los efectos de TRL obtenidas después de la ingesta de comidas que contenían AOO o aceite de oliva refinado (AOR) sobre la formación de células espumosas, uno de los pasos iniciales de la aterogénesis. Las comidas fueron administradas a 9 hombres sanos y las TRL fueron aisladas del suero sanguíneo 4h después de la ingesta. La ingesta de AOO dio lugar a TRL con menor ratio triglicéridos/apo B48 y triglicéridos/apo B100 en comparación con AOR. Tras la incubación de macrófagos THP-1 con las TRL, se observó un aumento en el contenido de triglicéridos intracelular y la formación de células espumosas. En comparación con TRL-AOR, el único receptor implicado en la captación de lipoproteínas que mostró cambios en la expresión génica después del tratamiento con TRL-AOO fue el receptor VLDL (VLDLr). En conclusión, la ingesta de AOR modificó la composición de TRL humanas, lo que aumentó la expresión de VLDLr en macrófagos, aunque los cambios no fueron suficientes para mejorar la formación de células espumosas.

Referencias bibliográficas

  • Abia R, Pacheco YM, Perona JS, Montero E, Muriana FJ, Ruiz-Gutiérrez V. 2001. The metabolic availability of dietary triacylglycerols from two high oleic oils during the postprandial period does not depend on the amount of oleic acid ingested by healthy men. J. Nutr. 131, 59–65. PMid:11208939
  • Awad AB, Begdache LA, Fink CS. 2000. Effect of sterols and fatty acids on growth and triglyceride accumulation in 3T3-L1 cells. J. Nutr. Biochem. 11, 153–158. http://dx.doi.org/10.1016/S0955-2863(99)00087-X
  • Cabello-Moruno R, Perona JS, Osada J, Garcia M, Ruiz-Gutierrez V. 2007. Modifications in postprandial triglyceride-rich lipoprotein composition and size after the intake of pomace olive oil. J. Am. Coll. Nutr. 26, 24–31. http://dx.doi.org/10.1080/07315724.2007.10719582 PMid:17353580
  • Cabello-Moruno, R, Sinausia, L, Botham, KM, Montero, E, Avella, M, Perona JS. 2014. Postprandial phase time influences uptake of triacylglycerol from postprandial triacylglycerol- rich lipoproteins in THP-1 macrophages. Br. J. Nutr. 23, 1–9.
  • Cárdeno A, Sánchez-Hidalgo M, Cortes-Delgado A, Alarcón de la Lastra C. 2013. Mechanisms involved in the antiproliferative and proapoptotic effects of unsaponifiable fraction of extra virgin olive oil on HT-29 cancer cells. Nutr. Cancer 65, 908–918. http://dx.doi.org/10.1080/01635581.2013.806674 PMid:23909736
  • Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Watts GF; European Atherosclerosis Society Consensus Panel. 2011. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J. 32, 1345–1361. http://dx.doi.org/10.1093/eurheartj/ehr112 PMid:21531743 PMCid:PMC3105250
  • Dushkin MI, Khoshchenko OM, Posokhova EN, Schvarts Ysh. 2007. Agonists of PPAR-alpha, PPAR-gamma, and RXR inhibit the formation of foam cells from macrophages in mice with inflammation. Bull Exp. Biol. Med. 144, 713–716. http://dx.doi.org/10.1007/s10517-007-0413-3 PMid:18683504 Eck MV, Oost J, Goudriaan JR, Hoekstra M, Hildebrand RB, Bos IS, van Dijk KW, Van Berkel TJ. 2005. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis 183, 230–237. http://dx.doi.org/10.1016/j.atherosclerosis.2005.03.045 PMid:15979629
  • Elsegood CL, Pal S, Roach PD, Mamo JC. 2001. Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins. Clin Sci (Lond). 101, 111–119. http://dx.doi.org/10.1042/cs1010111
  • Folch J, Lees M, Sloane-Stanley GH. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497–509. PMid:13428781
  • Goudriaan JR, Espirito Santo SM, Voshol PJ, Teusink B, van Dijk KW, van Vlijmen BJ, Romijn JA, Havekes LM, Rensen PC. 2004. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481. http://dx.doi.org/10.1194/jlr.M400009-JLR200 PMid:15145981
  • Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Ochoa-Herrera J, Perez-Lopez P, Pulido-Moran M, Ramirez- Tortosa MC. 2012. Squalene ameliorates atherosclerotic lesions through the reduction of CD36 scavenger receptor expression in macrophages. Mol. Nutr. Food Res. 56, 733–740. http://dx.doi.org/10.1002/mnfr.201100703 PMid:22648620
  • Jackson KG, Poppitt SD, Minihane AM. 2012. Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 220, 22–33. http://dx.doi.org/10.1016/j.atherosclerosis.2011.08.012 PMid:21955695
  • Jackson KG, Robertson MD, Fielding BA, Frayn KN, Williams CM. 2002. Measurement of apolipoprotein B-48 in the Svedberg flotation rate (S(f))>400, S(f) 60–400 and S(f) 20–60 lipoprotein fractions reveals novel findings with respect to the effects of dietary fatty acids on triacylglycerol-rich lipoproteins in postmenopausal women. Clin. Sci. (Lond) 103, 227–237. http://dx.doi.org/10.1042/cs1030227
  • Karpe F, Hamsten A. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35, 1311–1317. PMid:7964192
  • Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685. http://dx.doi.org/10.1038/227680a0 PMid:5432063
  • Mamo JC, Wheeler JR. 1994. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coron. Artery Dis. 5, 695–705. http://dx.doi.org/10.1097/00019501-199408000-00008 PMid:8000623
  • Moore EH, Bejta F, Avella M, Suckling KE, Botham KM. 2005. Efflux of lipid from macrophages after induction of lipid accumulation by chylomicron remnants. Biochim Biophys Acta 1735, 20–29. http://dx.doi.org/10.1016/j.bbalip.2005.04.009 PMid:15951238
  • Napolitano M, Avella M, Botham KM, Bravo E. 2003. Chylomicron remnant induction of lipid accumulation in J774 macrophages is associated with up-regulation of triacylglycerol synthesis which is not dependent on oxidation of the particles. Biochim. Biophys. Acta 1631, 255–264. http://dx.doi.org/10.1016/S1388-1981(03)00042-8
  • Noa M, de la Rosa MC, Más R. 1996. Effect of policosanol on foam-cell formation in carrageenan-induced granulomas in rats. J. Pharm. Pharmacol. 48, 306–309. http://dx.doi.org/10.1111/j.2042-7158.1996.tb05922.x PMid:8737059
  • Palmer AM, Nova E, Anil E, Jackson K, Bateman P, Wolstencroft E, Williams CM, Yaqoob P. 2005. Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages. Atherosclerosis 180, 233–244. http://dx.doi.org/10.1016/j.atherosclerosis.2004.12.038 PMid:15910848
  • Pérez-Martínez P, Ordovas JM, Garcia-Ríos A, Delgado-Lista J, Delgado-Casado N, Cruz-Teno C, Camargo A, Yubero-Serrano EM, Rodriguez F, Perez-Jimenez F, Lopez-Miranda J. 2011. Consumption of diets with different type of fat influences triacylglycerol-rich lipoproteins particle number and size during the postprandial state. Nutr. Metab. Cardiovasc. Dis. 21, 39–45. http://dx.doi.org/10.1016/j.numecd.2009.07.008 PMid:19819118
  • Perona JS, Avella M, Botham KM, Ruiz-Gutiérrez V. 2008. Differential modulation of hepatic very low-density lipoprotein secretion by triacylglycerol-rich lipoproteins derived from different oleic-acid rich dietary oils. Br. J. Nutr. 99, 29–36. http://dx.doi.org/10.1017/S0007114507793868 PMid:17651518
  • Perona JS, Cabello-Moruno R, Ruiz-Gutierrez V. 2006. The role of virgin olive oil components in the modulation of endothelial function. J. Nutr. Biochem. 17, 429–445. http://dx.doi.org/10.1016/j.jnutbio.2005.11.007 PMid:16481154
  • Perona JS, Ruiz-Gutierrez V. 2004. Quantification of major lipid classes in human triacylglycerol-rich lipoproteins by high-performance liquid chromatography with evaporative light-scattering detection. J. Sep. Sci. 27, 653–659. http://dx.doi.org/10.1002/jssc.200301723 PMid:15387459
  • Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45 PMid:11328886 PMCid:PMC55695
  • Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP. 2009. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J. Nutr. 139, 1143–1149. http://dx.doi.org/10.3945/jn.108.103481 PMid:19403719
  • Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT. 2004. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J. Atheroscler. Thromb. 11, 200–208. http://dx.doi.org/10.5551/jat.11.200 PMid:15356379
  • Vejux A, Montange T, Martine L, Zarrouk A, Riedinger JM, Lizard G. 2012. Absence of oxysterol-like side effects in human monocytic cells treated with phytosterols and oxyphytosterols. J. Agric. Food Chem. 60, 4060–4066. http://dx.doi.org/10.1021/jf300487r PMid:22490085
  • Wallert M, Mosig S, Rennert K, Funke H, Ristow M, Pellegrino RM, Cruciani G, Galli F, Lorkowski S, Birringer M. 2014. Long-chain metabolites of α-tocopherol occur in human serum and inhibit macrophage foam cell formation in vitro. Free Radic Biol Med. 68, 43–51. http://dx.doi.org/10.1016/j.freeradbiomed.2013.11.009 PMid:24296243
Fuente de los datos: Dialnet